ClearPoint Neuro (CLPT) Revenue & Revenue Breakdown
ClearPoint Neuro Revenue Highlights
Latest Revenue (Y)
$23.95M
Latest Revenue (Q)
$7.86M
Main Segment (Y)
Biologics and Drug Delivery Revenue
ClearPoint Neuro Revenue by Period
ClearPoint Neuro Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $23.95M | 16.56% |
| 2022-12-31 | $20.55M | 26.09% |
| 2021-12-31 | $16.30M | 27.05% |
| 2020-12-31 | $12.83M | 14.37% |
| 2019-12-31 | $11.22M | 52.54% |
| 2018-12-31 | $7.35M | -0.36% |
| 2017-12-31 | $7.38M | 28.35% |
| 2016-12-31 | $5.75M | 25.15% |
| 2015-12-31 | $4.59M | 27.46% |
| 2014-12-31 | $3.60M | -8.30% |
| 2013-12-31 | $3.93M | -22.29% |
| 2012-12-31 | $5.06M | 32.48% |
| 2011-12-31 | $3.82M | 43.03% |
| 2010-12-31 | $2.67M | - |
ClearPoint Neuro generated $23.95M in revenue during NA 2023, up 16.56% compared to the previous quarter, and up 325.77% compared to the same period a year ago.
ClearPoint Neuro Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $7.86M | 2.87% |
| 2024-03-31 | $7.64M | 12.17% |
| 2023-12-31 | $6.81M | 18.19% |
| 2023-09-30 | $5.76M | -3.16% |
| 2023-06-30 | $5.95M | 9.52% |
| 2023-03-31 | $5.43M | 5.01% |
| 2022-12-31 | $5.17M | 0.54% |
| 2022-09-30 | $5.15M | -1.04% |
| 2022-06-30 | $5.20M | 3.36% |
| 2022-03-31 | $5.03M | 17.49% |
| 2021-12-31 | $4.28M | -6.38% |
| 2021-09-30 | $4.57M | 34.02% |
| 2021-06-30 | $3.41M | -15.31% |
| 2021-03-31 | $4.03M | 8.45% |
| 2020-12-31 | $3.72M | 5.59% |
| 2020-09-30 | $3.52M | 42.03% |
| 2020-06-30 | $2.48M | -20.47% |
| 2020-03-31 | $3.12M | -2.96% |
| 2019-12-31 | $3.21M | 9.67% |
| 2019-09-30 | $2.93M | 12.32% |
| 2019-06-30 | $2.61M | 5.41% |
| 2019-03-31 | $2.47M | 8.61% |
| 2018-12-31 | $2.28M | 25.98% |
| 2018-09-30 | $1.81M | 9.76% |
| 2018-06-30 | $1.65M | 1.41% |
| 2018-03-31 | $1.62M | -3.34% |
| 2017-12-31 | $1.68M | -2.20% |
| 2017-09-30 | $1.72M | -13.10% |
| 2017-06-30 | $1.98M | -1.55% |
| 2017-03-31 | $2.01M | 22.75% |
| 2016-12-31 | $1.64M | 1.16% |
| 2016-09-30 | $1.62M | 46.42% |
| 2016-06-30 | $1.10M | -20.82% |
| 2016-03-31 | $1.39M | -7.77% |
| 2015-12-31 | $1.51M | 21.28% |
| 2015-09-30 | $1.25M | 50.95% |
| 2015-06-30 | $825.74K | -18.28% |
| 2015-03-31 | $1.01M | 5.27% |
| 2014-12-31 | $959.84K | 51.58% |
| 2014-09-30 | $633.20K | -46.74% |
| 2014-06-30 | $1.19M | 44.54% |
| 2014-03-31 | $822.53K | -30.08% |
| 2013-12-31 | $1.18M | 26.84% |
| 2013-09-30 | $927.46K | 64.88% |
| 2013-06-30 | $562.49K | -55.51% |
| 2013-03-31 | $1.26M | -32.13% |
| 2012-12-31 | $1.86M | 64.57% |
| 2012-09-30 | $1.13M | 4.44% |
| 2012-06-30 | $1.08M | 10.59% |
| 2012-03-31 | $980.00K | -15.82% |
| 2011-12-31 | $1.16M | 0.80% |
| 2011-09-30 | $1.15M | 59.76% |
| 2011-06-30 | $722.89K | - |
ClearPoint Neuro generated $7.86M in revenue during Q2 2024, up 2.87% compared to the previous quarter, and up 144.63% compared to the same period a year ago.
ClearPoint Neuro Revenue Breakdown
ClearPoint Neuro Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| Functional Neurosurgery Navigation and Therapy - Disposable Products | $7.59M | $7.59M | $7.70M | - | - |
| Functional Neurosurgery Navigation and Therapy | $8.52M | $9.12M | $8.07M | - | - |
| Biologics and Drug Delivery - Disposable Products | $2.15M | $3.69M | $3.35M | - | - |
| Biologics and Drug Delivery Revenue | $13.60M | $9.12M | $6.79M | $5.04M | - |
| Capital Equipment and Software - Services | $973.00K | $795.00K | $569.00K | - | - |
| Capital Equipment and Software - Systems and Software Products | $860.00K | $1.51M | $864.00K | - | - |
| Capital Equipment and Software Revenue | $1.83M | $2.31M | $1.43M | $1.49M | - |
| Functional Neurosurgery Navigation and Therapy - Services | $931.00K | $1.54M | $375.00K | - | - |
| Biologics and Drug Delivery - Services | - | - | $3.44M | - | - |
| Remaining Performance Obligations Capital Equipment-Related Service Revenue | - | - | - | - | $1.10M |
| Capital Equipment-Related Service Revenue | - | - | - | - | $228.00K |
ClearPoint Neuro's latest annual revenue breakdown by segment (product or service), as of Dec 23: Biologics and Drug Delivery Revenue (37.30%), Functional Neurosurgery Navigation and Therapy (23.37%), Functional Neurosurgery Navigation and Therapy - Disposable Products (20.81%), Biologics and Drug Delivery - Disposable Products (5.91%), Capital Equipment and Software Revenue (5.03%), Capital Equipment and Software - Services (2.67%), Functional Neurosurgery Navigation and Therapy - Services (2.55%), and Capital Equipment and Software - Systems and Software Products (2.36%).
Quarterly Revenue by Product
| Product/Service | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Functional Neurosurgery Navigation and Therapy - Disposable Products | $1.93M | $2.04M | $1.87M | $1.82M | $1.86M | $2.04M | $1.80M | $1.86M | - | - | - | - | - | - | - | - | - | - | - | - |
| Functional Neurosurgery Navigation and Therapy - Services | - | $1.00K | $44.00K | $383.00K | $503.00K | $375.00K | $375.00K | $375.00K | - | - | - | - | - | - | - | - | - | - | - | - |
| Capital Equipment And Software - Services | $250.00K | $276.00K | $208.00K | $218.00K | $193.00K | $185.00K | $189.00K | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Biologics And Drug Delivery - Disposable Products | $553.00K | $455.00K | $346.00K | $594.00K | $798.00K | $1.23M | $850.00K | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Functional Neurosurgery Navigation and Therapy | $1.93M | $2.04M | $1.92M | $2.20M | $2.36M | $2.42M | $2.17M | $2.24M | $2.14M | - | - | - | - | - | - | - | - | - | - | - |
| Biologics And Drug Delivery | $4.31M | $3.49M | $3.37M | $2.68M | $2.25M | $2.41M | $2.15M | $72.50K | $244.95K | $284.91K | - | - | - | - | - | - | - | - | - | - |
| Capital Equipment And Software | $1.41M | $357.00K | $381.00K | $396.00K | $480.00K | $619.00K | $639.00K | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Capital Equipment And Software - Systems and Software Products | $1.16M | $81.00K | $173.00K | $178.00K | $287.00K | $434.00K | $450.00K | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Biologics And Drug Delivery - Services | - | - | - | - | - | $1.45M | $1.18M | $1.30M | - | - | - | - | - | - | - | - | - | - | - | - |
| Biologics and Drug Delivery - Disposable Products | - | - | - | - | - | - | - | - | $852.00K | - | - | - | - | - | - | - | - | - | - | - |
| Biologics and Drug Delivery - Services | - | - | - | - | - | - | - | - | $837.00K | - | - | - | - | - | - | - | - | - | - | - |
| Biologics and Drug Delivery Revenue | - | - | - | - | - | - | - | - | $1.69M | $1.66M | - | - | - | - | - | - | - | - | - | - |
| Capital Equipment and Software - Services | - | - | - | - | - | - | - | - | $170.00K | - | - | - | - | - | - | - | - | - | - | - |
| Capital Equipment and Software - Systems and Software Products | - | - | - | - | - | - | - | - | $284.00K | - | - | - | - | - | - | - | - | - | - | - |
| Capital Equipment and Software Revenue | - | - | - | - | - | - | - | - | $454.00K | $453.00K | - | - | - | - | - | - | - | - | - | - |
| Remaining Performance Obligations Capital Equipment-Related Service Revenue | - | - | - | - | - | - | - | - | - | $800.00K | - | $-320.00K | $992.00K | - | - | - | - | - | - | - |
| Capital Equipment Related Service Revenue | - | - | - | - | - | - | - | - | - | $100.00K | $90.00K | - | - | - | - | - | - | - | - | - |
| Capital Equipment-Related Service Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $217.00K | $89.00K | $121.00K | - | - | - | - | - |
| Capital Equipment and Software Revenue Subtotal | - | - | - | - | - | - | - | - | - | - | - | - | - | $204.56K | - | - | - | - | - | - |
| Biologics and Drug Delivery Revenue Subtotal | - | - | - | - | - | - | - | - | - | - | - | - | - | $1.47M | - | - | - | - | - | - |
| Therapy Revenue Subtotal | - | - | - | - | - | - | - | - | - | - | - | - | - | $103.80K | - | - | - | - | - | - |
| Product Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $2.52M | - | - | - |
| Service and Other Revenues | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $686.77K | $333.04K | $412.20K | $308.56K |
| Capital Equipment | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $184.82K | $241.29K | $274.40K |
| Functional Neurology | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $1.85M | $1.69M | $1.60M |
| Product Revenues | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $2.59M | $2.19M | $2.16M |
| Therapy1Member | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $50.00K | - | - |
| Therapy | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $64.09K | $17.83K | - |
| Biologics and Drug Delivery | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $491.26K | - | - |
| Capital Equipment and Other | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $210.54K | $243.95K | $211.20K |
| BiologicsAndDrugDelivery1Member | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $168.25K | $97.36K |
ClearPoint Neuro's latest quarterly revenue breakdown by segment (product or service), as of Mar 24: Biologics And Drug Delivery (37.37%), Functional Neurosurgery Navigation and Therapy - Disposable Products (16.72%), Functional Neurosurgery Navigation and Therapy (16.72%), Capital Equipment And Software (12.19%), Capital Equipment And Software - Systems and Software Products (10.02%), Biologics And Drug Delivery - Disposable Products (4.80%), and Capital Equipment And Software - Services (2.17%).
ClearPoint Neuro Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| LIVN | LivaNova | $1.15B | $318.60M |
| SWAV | ShockWave Medical | $730.23M | $218.81M |
| INSP | Inspire Medical Systems | $624.80M | $195.88M |
| NARI | Inari Medical | $493.63M | $145.82M |
| INGN | Inogen | $315.66M | $88.77M |
| KIDS | OrthoPediatrics | $148.73M | $52.80M |
| SRDX | Surmodics | $132.58M | $30.34M |
| OM | Outset Medical | $130.38M | $27.39M |
| SGHT | Sight Sciences | $81.06M | $21.37M |
| LUNG | Pulmonx | $68.67M | $20.78M |
| NPCE | NeuroPace | $65.42M | $18.12M |
| TELA | TELA Bio | $58.45M | $16.09M |
| APYX | Apyx Medical | $52.35M | $12.15M |
| RCEL | AVITA Medical | $50.56M | $21.23M |
| CTSO | Cytosorbents | $36.35M | $9.79M |
| OSA | ProSomnus | $27.65M | $7.46M |
| TBIO | Telesis Bio | $27.51M | $3.44M |
| CLPT | ClearPoint Neuro | $23.95M | $7.86M |
CLPT Revenue FAQ
What is ClearPoint Neuro’s yearly revenue?
ClearPoint Neuro's yearly revenue for 2023 was $23.96M, representing an increase of 16.56% compared to 2022. The company's yearly revenue for 2022 was $20.55M, representing an increase of 26.09% compared to 2021. CLPT's yearly revenue for 2021 was $16.3M, representing an increase of 27.05% compared to 2020.
What is ClearPoint Neuro’s quarterly revenue?
ClearPoint Neuro's quarterly revenue for Q2 2024 was $7.86M, a 2.87% increase from the previous quarter (Q1 2024), and a 32.07% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $7.64M, a 12.17% increase from the previous quarter (Q4 2023), and a 40.60% increase year-over-year (Q1 2023). CLPT's quarterly revenue for Q4 2023 was $6.81M, a 18.19% increase from the previous quarter (Q3 2023), and a 31.62% increase year-over-year (Q4 2022).
What is ClearPoint Neuro’s revenue growth rate?
ClearPoint Neuro's revenue growth rate for the last 3 years (2021-2023) was 46.97%, and for the last 5 years (2019-2023) was 113.56%.
What are ClearPoint Neuro’s revenue streams?
ClearPoint Neuro's revenue streams in c 23 are Functional Neurosurgery Navigation and Therapy - Disposable Products, Functional Neurosurgery Navigation and Therapy, Biologics and Drug Delivery - Disposable Products, Biologics and Drug Delivery Revenue, Capital Equipment and Software - Services, Capital Equipment and Software - Systems and Software Products, Capital Equipment and Software Revenue, and Functional Neurosurgery Navigation and Therapy - Services. Functional Neurosurgery Navigation and Therapy - Disposable Products generated $7.59M in revenue, accounting 20.81% of the company's total revenue, up 0.03% year-over-year. Functional Neurosurgery Navigation and Therapy generated $8.52M in revenue, accounting 23.37% of the company's total revenue, down -6.62% year-over-year. Biologics and Drug Delivery - Disposable Products generated $2.15M in revenue, accounting 5.91% of the company's total revenue, down -41.63% year-over-year. Biologics and Drug Delivery Revenue generated $13.6M in revenue, accounting 37.30% of the company's total revenue, up 49.14% year-over-year. Capital Equipment and Software - Services generated $973K in revenue, accounting 2.67% of the company's total revenue, up 22.39% year-over-year. Capital Equipment and Software - Systems and Software Products generated $860K in revenue, accounting 2.36% of the company's total revenue, down -43.12% year-over-year. Capital Equipment and Software Revenue generated $1.83M in revenue, accounting 5.03% of the company's total revenue, down -20.55% year-over-year. Functional Neurosurgery Navigation and Therapy - Services generated $931K in revenue, accounting 2.55% of the company's total revenue, down -39.43% year-over-year.
What is ClearPoint Neuro’s main source of revenue?
For the fiscal year ending Dec 23, the largest source of revenue of ClearPoint Neuro was Biologics and Drug Delivery Revenue. This segment made a revenue of $13.6M, representing 37.30% of the company's total revenue.